OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Abemaciclib pharmacology and interactions in the treatment of HR+/HER2− breast cancer: a critical review
Federica Martorana, Maria Vita Sanò, Maria Rosaria Valerio, et al.
Therapeutic Advances in Drug Safety (2024) Vol. 15
Open Access | Times Cited: 7
Federica Martorana, Maria Vita Sanò, Maria Rosaria Valerio, et al.
Therapeutic Advances in Drug Safety (2024) Vol. 15
Open Access | Times Cited: 7
Showing 7 citing articles:
CDK4 selective inhibition improves preclinical anti-tumor efficacy and safety
Cynthia L. Palmer, Britton Boras, Bernadette Pascual, et al.
Cancer Cell (2025) Vol. 43, Iss. 3, pp. 464-481.e14
Open Access | Times Cited: 3
Cynthia L. Palmer, Britton Boras, Bernadette Pascual, et al.
Cancer Cell (2025) Vol. 43, Iss. 3, pp. 464-481.e14
Open Access | Times Cited: 3
Recent Treatment Strategies and Molecular Pathways in Resistance Mechanisms of Antiangiogenic Therapies in Glioblastoma
Md. Ataur Rahman, Meser M. Ali
Cancers (2024) Vol. 16, Iss. 17, pp. 2975-2975
Open Access | Times Cited: 11
Md. Ataur Rahman, Meser M. Ali
Cancers (2024) Vol. 16, Iss. 17, pp. 2975-2975
Open Access | Times Cited: 11
CDK4/6 as a Therapeutic Target in HR+/HER2− Breast Cancer Cells—Current Treatment Status
Katherine Krupa, Anna Liszcz-Tymoszuk, Natalia Czerw, et al.
Cancers (2025) Vol. 17, Iss. 6, pp. 1039-1039
Open Access | Times Cited: 1
Katherine Krupa, Anna Liszcz-Tymoszuk, Natalia Czerw, et al.
Cancers (2025) Vol. 17, Iss. 6, pp. 1039-1039
Open Access | Times Cited: 1
Significant Influence of Abemaciclib on Rivaroxaban
Xiaoshuang He, Yongjie Ding, Jie Fang, et al.
Therapeutic Drug Monitoring (2025)
Closed Access
Xiaoshuang He, Yongjie Ding, Jie Fang, et al.
Therapeutic Drug Monitoring (2025)
Closed Access
Real-World Analysis of Adherence to Abemaciclib and Endocrine Therapy in Women with HR+/HER2− Breast Cancer
Maria Rosaria Valerio, Federica Martorana, Maria Vita Sanò, et al.
Biomedicines (2025) Vol. 13, Iss. 3, pp. 546-546
Open Access
Maria Rosaria Valerio, Federica Martorana, Maria Vita Sanò, et al.
Biomedicines (2025) Vol. 13, Iss. 3, pp. 546-546
Open Access
Unusual presentation of luminal breast carcinoma metastatic to the brain and coma: a case report of dramatic response to abemaciclib and literature review
Maria Rosaria Valerio, Calogero Cipolla, Martina Greco, et al.
Therapeutic Advances in Medical Oncology (2025) Vol. 17
Open Access
Maria Rosaria Valerio, Calogero Cipolla, Martina Greco, et al.
Therapeutic Advances in Medical Oncology (2025) Vol. 17
Open Access
CDK4/6 inhibitors in breast cancer therapy: mechanisms of drug resistance and strategies for treatment
Tong Gao, Ying Sun, Ping Leng, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Tong Gao, Ying Sun, Ping Leng, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
